Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Hepatocellular 2Stomach Neoplasms 1Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety 1Lung Neoplasms 1Liver Neoplasms 1Glioma 1Glioblastoma 1Breast Cancer Organoids 1Advanced Gastric Cancer 1

Interventions

Temozolomide 12Magnetic Resonance Spectroscopy 9Radiotherapy 6Surveys and Questionnaires 5Blood Specimen Collection 4Transurethral Resection of Bladder 3Surgical Procedures, Operative 3Radiation 3Perfusion Magnetic Resonance Imaging 2Magnetic Resonance Imaging 2Lomustine 2Immunotherapy 2Drug Therapy 2Chemoradiotherapy 2Amplified Fragment Length Polymorphism Analysis 2regorafenib 1lentiviral minigene vaccine of COVID-19 coronavirus 1gadodiamide 1apatinib 1Ultrasonography 1Trail Making Test 1Therapies, Investigational 1Tablets 1Standard of Care 1Specimen Handling 1Sampling Studies 1Re-Irradiation 1Quality of Life 1Psychometrics 1Proton Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Glioblastoma × apatinib × Clear all
NCT03567135 2020-03-03

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Fuzhou General Hospital

Unknown
60 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡